MASSANO, DAVIDE

MASSANO, DAVIDE  

SCIENZE DELLA SANITA' PUBBLICA E PEDIATRICHE  

Mostra records
Risultati 1 - 16 di 16 (tempo di esecuzione: 0.017 secondi).
Titolo Data di pubblicazione Autore(i) File
A new HPLC UV validated method for therapeutic monitoring of deferasirox in thalassaemic patients. 2012 De Francia S; Massano D; Piccione FM; Pirro E; Racca S; Di Carlo F; Piga A.
Clinical relevance of deferasirox trough levels in β-thalassemia patients 2018 Allegra, Sarah; Massano, Davide; De Francia, Silvia; Longo, Filomena; Piccione, Francesca; Pirro, Elisa; Cusato, Jessica; D'Avolio, Antonio; Piga, Antonio
Deferasirox AUC efficacy cutoff and role of pharmacogenetics 2016 Allegra, S; Cusato, J; De Francia, S; Massano, D; Piga, A; D'Avolio, A
Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patients 2017 Allegra, Sarah; De Francia, Silvia; Cusato, Jessica; Arduino, Arianna; Massano, Davide; Longo, Filomena; Piga, Antonio; D'Avolio, Antonio
Deferasirox pharmacokinetic and toxicity correlation in β-thalassaemia major treatment 2016 Allegra, Sarah; De Francia, Silvia; Cusato, Jessica; Pirro, Elisa; Massano, Davide; Piga, Antonio; D'Avolio, Antonio
Deferasirox pharmacokinetic evaluation in β-thalassaemia paediatric patients 2017 Allegra, Sarah; Cusato, Jessica; De Francia, Silvia; Pirro, Elisa; Massano, Davide; Piga, Antonio; D'Avolio, Antonio
Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous β-thalassaemia 2016 Allegra, Sarah; De Francia, Silvia; Longo, Filomena; Massano, Davide; Cusato, Jessica; Arduino, Arianna; Pirro, Elisa; Piga, Antonio; D'Avolio, Antonio
Deferiprone 2010 A. Piga; S. Roggero; I. Salussolia; D. Massano; M. Serra; F. Longo
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children 2016 Sarah Allegra, Jessica Cusato, Silvia De Francia, Arianna Arduino, Filomena Longo, Davide Massano, Antonio Piga, Antonio D'Avolio
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children 2018 Allegra, Sarah; Cusato, Jessica; De Francia, Silvia; Longo, Filomena; Pirro, Elisa; Massano, Davide; Piga, Antonio; D'Avolio, Antonio
Influence of single-nucleotide polymorphisms on deferasirox C-trough levels and effectiveness 2014 Cusato, J; Allegra, S; Massano, D; De Francia, S; Piga, A; D'Avolio, A.
Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients 2018 Allegra, Sarah; Cusato, Jessica; De Francia, Silvia; Longo, Filomena; Pirro, Elisa; Massano, Davide; Avataneo, Valeria; De Nicolò, Amedeo; Piga, Antonio; D'Avolio, Antonio
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes 2016 Sarah Allegra, Silvia De Francia, Jessica Cusato, Arianna Arduino, Elisa Pirro, Davide Massano, Filomena Longo, Antonio Piga, Antonio D'Avolio.
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes 2018 Allegra, Sarah; Cusato, Jessica; DE FRANCIA, Silvia; Arduino, A; Longo, Filomena; Pirro, Elisa; Massano, Davide; DE NICOLO', Amedeo; Piga, Antonio Giulio; D'Avolio, Antonio
Role of pharmacogenetics on deferasirox AUC and efficacy 2016 Cusato, Jessica; Allegra, Sarah; DE FRANCIA, Silvia; Massano, Davide; Piga, Antonio Giulio; D'Avolio, Antonio
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients 2019 Allegra, Sarah; Cusato, Jessica; De Francia, Silvia; Longo, Filomena; Pirro, Elisa; Massano, Davide; Avataneo, Valeria; De Nicolò, Amedeo; Piga, Antonio; D'Avolio, Antonio